Jazz Pharma's decision to revoke U.S. patent for rival narcolepsy drug

Published Date: 02 Mar 2023

A U.S. court on Friday ordered Jazz Pharmaceuticals to revoke its patents related to its flagship narcolepsy drug Xyrem from the FDA-approved brand name drug after winning a case against Avadel foe CNS Pharmaceuticals.

Read Full News

Latest News

Kimberly-Clark to buy Tylenol owner Kenvue in $48.7 bn deal

US consumer goods giant Kimberly-Clark announced Monday a $48.7 billion deal to acquire the major health company Kenvue, whose Tylenol painkiller has faced Trump administration allegations of links to increased autism risks.

Companion chatbots found to have fewer safeguards for teens than general-assistant chatbots

Companion chatbots featured fewer safeguards related to adolescent health crises than general-assistant chatbots, according to a research letter published online Oct. 23 in JAMA Network Open.

AI tool detects structural heart disease in adults using a smartwatch

An artificial intelligence (AI) algorithm paired with the single-lead electrocardiogram (ECG) sensors on a smartwatch accurately diagnosed structural heart diseases, such as weakened pumping ability, damaged valves or thickened ...

Neural implant smaller than a grain of salt can wirelessly track brain

Cornell University researchers and collaborators have developed a neural implant so small that it can rest on a grain of salt, yet it can wirelessly transmit brain activity data in a living animal for more than a year.

FDA issues safety alert for radiofrequency microneedling

The U.S. Food and Drug Administration (FDA) is warning consumers, patients and health care providers about the potential risk for serious complications from radiofrequency (RF) microneedling procedures.

A revised standard on respirators should help us all breathe easier

The CSA Group—a not-for-profit standards organization—released for review a new draft standard on the "Selection, Use, and Care of Respirators" (CSA Z94.4:25) for workplaces, specifically including health care. This new ...

Todays Updates

Is global cancer care losing its human touch?

A new Lancet Oncology Commission highlights a growing "human crisis" in cancer care. Despite advances in treatment and increased survival rates, many patients worldwide are not receiving the compassionate, holistic support ...

How access to specialized cancer centers affects glioblastoma outcomes

Glioblastoma is one of the most aggressive and complex brain cancers. It grows quickly, resists standard treatments, and often leaves patients and their families searching for every possible option.

Sustained reduction found in prostate cancer mortality with prostate-specific antigen screening

A European study has demonstrated a sustained long-term reduction in prostate cancer mortality through prostate-specific antigen (PSA) screening. However, the findings also highlight the issue of overdiagnosis, or the detection ...

Todays Updates

Is global cancer care losing its human touch?

A new Lancet Oncology Commission highlights a growing "human crisis" in cancer care. Despite advances in treatment and increased survival rates, many patients worldwide are not receiving the compassionate, holistic support ...

How access to specialized cancer centers affects glioblastoma outcomes

Glioblastoma is one of the most aggressive and complex brain cancers. It grows quickly, resists standard treatments, and often leaves patients and their families searching for every possible option.

Sustained reduction found in prostate cancer mortality with prostate-specific antigen screening

A European study has demonstrated a sustained long-term reduction in prostate cancer mortality through prostate-specific antigen (PSA) screening. However, the findings also highlight the issue of overdiagnosis, or the detection ...

Latest News

US consumer goods giant Kimberly-Clark announced Monday a $48.7 billion deal to acquire the major health company Kenvue, whose Tylenol painkiller has faced Trump administration allegations of links to increased autism risks.

Companion chatbots featured fewer safeguards related to adolescent health crises than general-assistant chatbots, according to a research letter published online Oct. 23 in JAMA Network Open.

An artificial intelligence (AI) algorithm paired with the single-lead electrocardiogram (ECG) sensors on a smartwatch accurately diagnosed structural heart diseases, such as weakened pumping ability, damaged valves or thickened ...

Cornell University researchers and collaborators have developed a neural implant so small that it can rest on a grain of salt, yet it can wirelessly transmit brain activity data in a living animal for more than a year.

The U.S. Food and Drug Administration (FDA) is warning consumers, patients and health care providers about the potential risk for serious complications from radiofrequency (RF) microneedling procedures.

The CSA Group—a not-for-profit standards organization—released for review a new draft standard on the "Selection, Use, and Care of Respirators" (CSA Z94.4:25) for workplaces, specifically including health care. This new ...

News All Time

Nerve signal detection method shows potential for intentional control of bionic prostheses

Despite enormous progress in the past two decades, the intentional control of bionic prostheses remains a challenge and the subject of intensive research. Now, scientists at the Medical University of Vienna and Imperial College ...

Couple conceive with the help of an AI-guided sperm recovery method

After trying to start a family for nearly two decades, a couple has conceived with the help of researchers at the Columbia University Fertility Center. The case is described in a research letter published in The Lancet. It ...

Women folk healers were branded as witches, but their treatments may have been medically sound

"Double double toil and trouble" is a quote from Shakespeare's Macbeth that conjures images of evil witches making potions in giant cauldrons. But the truth was that women persecuted as witches were probably legitimate healers ...

Experimental cancer drug shows exceptional tumor-fighting potential

A research team has developed a new chemotherapeutic agent, LiPyDau, which shows remarkable efficacy against multiple tumor types in preclinical studies. Published in the journal Molecular Cancer, the study introduces a highly ...

Atorvastatin recall may affect hundreds of thousands of patients, and reflects FDA's troubles

If you take cholesterol-lowering drugs called statins, you may have noticed a flurry of news coverage since late October 2025 about an extensive recall of thousands of bottles of atorvastatin, the generic version of Lipitor.

From antibiotics to antimalarials: How repurposed drugs might keep cancer from returning

Many cancer survivors live with the worry that their cancer might come back. This "recurrence" occurs when cancer cells hide somewhere in the body—like in the bone marrow—and start growing again, sometimes years later. ...

Antidepressants improve core depressive symptoms early on, analysis finds

One of the most common antidepressants, sertraline, contributes to a modest improvement in core depression and anxiety symptoms, including low mood, within two weeks, finds a new analysis of a major clinical trial led by ...

GLP-1 drugs effective for weight loss, but more independent studies needed

Three new Cochrane reviews find evidence that GLP-1 drugs result in clinically meaningful weight loss, but industry-funded studies raise questions. The reviews were commissioned by the World Health Organization (WHO) to inform ...

Should toddlers try peanuts? Is your ulcer a bug's fault? The 'flip-flopping' of health advice

In the early 2000s, the advice for parents was clear: Don't feed babies and toddlers foods containing peanuts. It might increase the child's risk of developing a severe allergy to the ground nut.

An app, an Apple Watch and AI: A new way for researchers to study sleep health

An app that turns consumer Apple Watches into tools for highly sophisticated sleep stage monitoring was developed by a team of researchers led by professor Joyita Dutta at the University of Massachusetts Amherst. The researchers ...

AI digital twins help patients make smarter decisions about knee surgery, study finds

An AI-powered tool helped patients make more confident, personalized decisions about knee replacement surgery—and led to better outcomes months later—according to a new study from researchers at Dell Medical School at ...

First online app for selecting best AI models for treatment of individual organs could help patients and physicians

A team from the Department of Electronics, Information and Bioengineering of the Politecnico di Milano, led by Dr. Andrea Moglia, has developed the first online application that helps identify which artificial intelligence ...

Generative AI could be transformative in mental health care

New work by a University of Illinois Urbana-Champaign scholar harnesses the power of generative artificial intelligence, using it in tandem with measurement-based care and access-to-care models in a simulated case study, ...

Investor pressure may be driving risky AI medical device launches

AI is transforming health care, but a new study from researchers at Johns Hopkins, Georgetown, and Yale suggests we might be moving too fast to integrate the technology into clinical settings.

Children's views could help shape better mask design

A new study from the Durham University Psychology Department has found that children's views on the design and comfort of air pollution masks could be key to encouraging their regular use.

Blocking a key protein can double yield and increase potency of muscle-regenerating cells

If cancer is a disease of overabundance, where cells divide without restraint and tumors grow despite the body's best interests, then degenerative diseases are disorders of deprivation. When malfunctions occur in the biological ...

Recommended News For You

Top Options Are Discovered Through Direct Comparison of 25 Migraine Drugs.

Researchers use genomic technology to investigate aggressive skin cancer linked to burn scars

Prostate cancer relapse after radiotherapy is strongly predicted by biological markers.

Study identifies new target for obesity-related breast cancer

Quality of Life Similar With Proton Beam Therapy vs IMRT for Prostate Cancer

Use of social media during pregnancy may increase depression.

Emicizumab in Infants With Hemophilia A: Safe and Effective Use.

Recommended Articles For You

The Converging Frontiers of Radiation Oncology and Systemic Therapies by 2025 

IGSF8: A Rising Star in Cancer Immunotherapy - Harnessing the Innate Immune System 

Surprising Symptoms of Prostate Cancer: What You Need to Know 

Innovative Bioengineering Approaches for Erectile Function Recovery After Radical Prostatectomy 

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Immunotherapy after surgery is good for patients with advanced cancer

2.

Significant differences in breast cancer care still exist, but surgeons can change.

3.

Blinatumomab Plus Chemotherapy New Standard for Children With B-Cell ALL

4.

Even when they are not paying attention, children are still learning.

5.

Breast awareness: What to look for in your self-exam

1.

Revolutionizing Oncology Trials: Optimization, Matching, Diversity, and Decentralization

2.

Exploring the Causes and Treatments of Thrombocytopenia: A Comprehensive Guide

3.

Understanding Sideroblastic Anemia and its Symptoms 

4.

Esophageal Cancer Survival Rates and Outcomes: Evidence-Based Insights from Oncology Studies

5.

Revolutionizing Cancer Treatment: ESMO's Updated Recommendations for Tumour NGS

1.

International Lung Cancer Congress®

2.

Future NRG Oncology Meeting

3.

Genito-Urinary Oncology Summit 2026

4.

ISMB 2026 (Intelligent Systems for Molecular Biology)

5.

Annual International Congress on the Future of Breast Cancer East

1.

Treatment Sequencing Strategies in ALK + NSCLC Patients with CNS Diseases - Part II

2.

Revolutionizing Treatment of ALK Rearranged NSCLC with Lorlatinib - Part IV

3.

Navigating the Brain Barrier: The CNS Challenge in ALK+ NSCLC

4.

EGFR Mutation Positive Non-Small Cell Lung Cancer- Case Discussion & Conclusion

5.

Untangling The Best Treatment Approaches For ALK Positive Lung Cancer - Part I

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2025 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot